coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Swan Network Wigan PCN, Wigan (LAD) · Health Inequalities Profile

    PCN U69052 · NHS Greater Manchester Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    35,742

    Registered population

    59.8% aged 18–64

    21.6%

    Aged 65+

    ICB 14.9% · England 17.9%

    11.6%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~3,949

    Core20 residents (est.)

    Resident basis; registered basis ~4,231 · see page 3

    7,350

    Hypertension register

    +10.11% in 3 yrs · England +5.60%

    303

    SMI register

    8.5% of Wigan (LAD)'s

    952

    COPD register

    Reviews -0.75% in 3 yrs

    Forecast to 2030

    8,971

    Hypertension patients, 2030

    +1,621 on today

    73.2%

    QRISK ≥20% on statins, 2030

    +2.09pp over 3 yrs

    4.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    18
    Eighteen of 25 three-year trends trail England.

    Trailing changes include asthma reviews (-0.9% vs England +4.4%; 701 unreviewed scale indicator) and statins in diabetes with CVD (-1.0% vs England +1.0%).

    77.2%
    Strong current chronic disease control and reviews.

    Registered achievement exceeds England in hypertension treated to target (77.2% vs 70.3%), COPD reviews (87.0% vs 76.4%), and heart failure reviews (88.5% vs 78.5%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ represent 21.6% of the list, exceeding Wigan and England averages

    Swan Network Wigan PCN serves 35,742 registered patients across its practices. Patients aged 65+ make up 21.6% (7,731), above Wigan (18.8%), NHS Greater Manchester ICB (14.9%), and England (17.9%). Children aged 0–17 represent 18.5% (6,625), below Wigan (20.0%), the ICB (21.8%), and England (19.6%). Projected list growth to 2030 is 0.3% under an unverified projection methodology (Wigan 1.1%, ICB 1.6%, England 2.3%). Recorded Gypsy or Irish Traveller and Roma groups each represent 0.1% of residents. Primary care planning must account for an older demographic, although registered counts lack supplied observation periods and ethnicity uses Census data.

    Age profile

    0–1718.5%
    18–6459.8%
    65+21.6%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Wigan (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Wigan LA)2,7062,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.8%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)66.0%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Wigan LA)1,2431,0219552024/25
    Falls deaths, all ages, per 100,000 (Wigan LA)12.318.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is below England but spans 18.6 pp across member practices

    The PCN Core20 share is 11.6% (average IMD decile 6.0), below Wigan (LAD) at 29.4%, the ICB at 40.7%, and England at 21.0%. The weighted practice share is 11.8%, while resident deciles 1 and 2 counts total 3,949. Across practices, the Core20 range is 18.6 pp. South Wigan Medical Practice records 18.58% (1,208 estimated patients), Kumar Family Practice records 15.58% (808), Marus Bridge Practice records 14.88% (806), and Saxena L records 0.0%. Targeted outreach should focus on these three practices where Core20 volume concentrates.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    South Wigan18.6% · 1,208 patients
    Kumar15.6% · 808 patients
    Marus Bridge14.9% · 806 patients
    Zaman12.6% · 547 patients
    Bryn Cross10.1% · 551 patients
    Medicentre5.5% · 311 patients
    Saxena L0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    303

    SMI register

    0.85% recorded prevalence

    206

    Learning disability register

    0.58% recorded prevalence

    8

    Care homes, 372 beds

    In the PCN catchment

    10.1%

    Provide unpaid care

    Wigan (LAD), Census 2021

    Recorded learning disability prevalence is 0.6% (206 patients), below Wigan (0.7%) and matching the ICB (0.6%) and England (0.6%). Severe mental illness prevalence is 0.8% (303 patients), below Wigan (1.0%), the ICB (1.1%), and England (1.0%). The PCN catchment includes 8 care homes with 372 beds, though resident registrations are unconfirmed. Lower recorded prevalence on crude registers does not establish under-detection or unmet need.

    Severe mental illness: physical health checks

    Recorded severe mental illness prevalence is 0.8% (England 1.0%). Annual checks reach 92.0% for blood pressure (England 83.4%) and 92.0% for BMI (England 82.1%). Smoking cessation offers for qualifying conditions fell 2.5 pp (England +0.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,350

    Hypertension register

    +10.11%

    Register growth, 3 yrs

    Wigan (LAD) +10.59% · England +5.60%

    +1.66pp

    BP control, under 80

    ≤140/90 · +1.17pp aged 80+

    +1,621

    More patients by 2030

    Forecast 8,971 (25.05%)

    Hypertension case-finding and control

    Hypertension prevalence is 20.7% (7,350 patients), above Wigan (18.0%), NHS Greater Manchester ICB (14.4%), and England (15.2%), with three-year growth of +10.1% (England +5.6%). Clinical control remains high: 77.2% of hypertensive patients are treated to target versus 75.6% in Wigan, 71.4% in the ICB, and 70.3% in England. However, the three-year change in blood pressure control for patients aged under 80 was +2.2%, trailing Wigan (+6.2%), the ICB (+3.6%), and England (+3.2%). While blood pressure control currently exceeds comparators, trailing three-year progress indicates that proactive recall could be prioritised to sustain management as the register expands.

    Lipids and statins

    For patients with diabetes and CVD, statin coverage is 83.7%, below Wigan (84.6%), NHS Greater Manchester ICB (85.8%), and England (84.4%), following a -1.0% three-year change (England +1.0%). Lagging secondary prevention statin coverage against comparators suggests a targeted review of diabetic patients with cardiovascular disease could be prioritised to close treatment gaps.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202667,720£2.50£1.94£1.86£169,300
    Cardiovascular (all), 202586,691£5.63£3.15£3.33£488,070

    Lipid-regulating drugs (2026) cost £2.50 per item across 67,720 prescribed items, exceeding Wigan (£2.09), NHS Greater Manchester ICB (£1.94), and England (£1.86), or £43,341 more than at England's unit cost. Higher unit costs than comparators may reflect product choice or formulary mix, which a local prescribing audit could verify.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −0.94%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.98%

    Asthma prevalence, PCN 3-yr % change

    Recorded asthma prevalence is 8.6% (2,899 patients; England 6.6%) and COPD prevalence is 2.7% (952 patients; England 1.9%). Annual review rates exceed England for asthma (75.8% vs 65.7%) and COPD (87.0% vs 76.4%), though three-year changes were -0.9% (England +4.4%) and -0.8% (England +2.8%). A scale indicator estimates 701 asthma patients without a recorded review across the register. Asthma prescribing was 1,831 items per 1,000 aged 5–19 (England 1,488).

    Cancer register and children's immunisation

    Cancer QOF prevalence (all ages) is 3.9%, compared with 4.0% in Wigan (LAD), 3.3% in NHS Greater Manchester ICB, and 3.8% in England. Crude recorded prevalence does not establish undiagnosed disease or coding variation.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months100.0%

    England 91.0%

    6-in-1 complete primary course at 24 months97.4%

    England 92.2%

    MMR dose 1 at 24 months94.7%

    England 88.3%

    MMR dose 2 at age 597.4%

    England 82.8%

    4-in-1 pre-school booster at age 596.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In NHS Greater Manchester ICB (2022), 55.6% of cancers with a known stage (6,491 of 11,679) were diagnosed at stage 1 or 2, in line with England (55.3%) but at a distance of -19.4 pp to the 75.0% national ambition by 2028. Known-stage share was 70.8% (11,679 of 16,492 registered cancers). Sizing the gap to 75.0% indicates about 2,270 extra early diagnoses annually. System staging reflects ICB diagnostic pathways rather than PCN performance. Although PCN cervical screening reached 79.1% (England 66.8%), three-year coverage fell 1.9% (England -1.0%). Primary care coordination supports screening uptake.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For cancer waiting times (Jul 2026 (provisional)), Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust achieved 76.8% on the 62-day referral-to-treatment standard, with a distance of -8.2 pp to the 85.0% standard. This was behind North Cheshire and Mersey NHS Foundation Trust (83.7%) and Mersey and West Lancashire Teaching Hospitals NHS Trust (78.0%), but above NHS Greater Manchester Integrated Care Board (75.7%) and England (71.2%). On the 28-day faster diagnosis standard, Wrightington, Wigan and Leigh reached 82.8% (standard 75.0%), exceeding the ICB (79.5%) and England (79.3%). These trust metrics describe provider pathways rather than PCN performance.

    Pathways within standard (%)Wrightington, Wigan and LeighMersey and West LancashireNorth Cheshire and MerseyGreater Manchester ICBEngland
    28-day faster diagnosis (75%)82.8072.3980.2179.5379.32
    31-day treatment (96%)89.0495.4698.1796.4992.50
    62-day referral to treatment (85%)76.7877.9683.6775.7371.16
    Diagnostic waits over 6 weeks (%)Wrightington, Wigan and LeighMersey and West LancashireNorth Cheshire and MerseyEngland
    MRI0.4914.040.5321.40
    CT7.7813.082.329.92
    Echocardiography24.3734.8828.0428.48
    Colonoscopy6.1018.0415.9830.83
    Gastroscopy12.5418.1720.2429.02
    All 15 DM01 tests14.3621.176.3423.14
    Community services activityWigan residentsGreater Manchester ICB
    Care contacts48,150573,310
    Referrals13,75094,470
    Patients with a contact18,695183,535

    Community services (residents of Wigan), Jun 2026 (provisional). In the Community Services Dataset (Jun 2026 (provisional)), adults aged 65+ accounted for 58.5% of borough residents' community contacts (28,190 of 48,150 total contacts). Activity is reported at local authority level rather than PCN level. With 21.6% of PCN patients aged 65+, coordination between primary care and community teams supports chronic disease and older-age care pathways.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Ease of phone contact varies by 34.7 pp across network practices

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Zaman8412.698.6%88.3%99.3%
    South Wigan10518.689.4%69.5%96.2%
    Bryn Cross Surgery9710.193.0%74.9%95.2%
    Marus Bridge11814.970.1%71.2%91.3%
    Saxena L1120.089.4%74.1%88.6%
    Kumar9615.663.9%74.0%87.7%
    Medicentre1205.568.5%64.2%80.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWigan (LAD)AssetPCNWigan (LAD)
    Care homes (catchment)8 (372 beds)n/aSchools (catchment)41n/a
    Children's centres320Places of worship27164
    Librariesn/a10Primary schools (LA maintained)868
    Primary academies521Special schools23

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Targeted Core20 recall and outreach

    Core20 share spans 18.6 pp across practices (PCN 11.6% vs England 21.0%), from 0.0% at Saxena L to 18.58% (1,208 estimated patients) at South Wigan Medical Practice. For discussion: the PCN could prioritise proactive recall and tailored outreach at the practices with the highest Core20 share and volume. Moderate effort to run.

    Evidence base: the share of patients in the most deprived quintile is the Core20 targeting measure used to weight inequalities funding, outreach and prevention capacity, and the gradient every clinical indicator should be read against.

    Policy anchor: Core20PLUS5 (Core20 = the most deprived 20% by IMD); 10 Year Health Plan, with widening inequalities the equity test of reform.

    Option 2

    Asthma annual review recall audit

    Asthma reviews fell 0.9% over three years (England +4.4%; Wigan +0.9%), with a scale indicator of 701 patients without a recorded review out of 2,899 register patients (75.8% vs England 65.7%). For discussion: practices could run a structured asthma recall and inhaler check using a standardised review template. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Practice telephone access workflow review

    Ease of phone contact spans 34.7 pp across practices in the 2026 survey, from 63.9% at Kumar Family Practice to 98.6% at Zaman (England 56.9%; response rates 23.9% to 27.8%). For discussion: practices could review peak call-handling capacity, triage routing, and shared access protocols starting where phone ratings are lowest. Moderate effort to run.

    Evidence base: patient-reported access and experience is the demand-side signal on primary-care capacity and access model; practices with sustained poor experience are the ones to prioritise for access-model support.

    Policy anchor: 10 Year Health Plan, shift from hospital to community (Neighbourhood Health Service).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Anticipatory frailty care (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation offer audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension review audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Targeted Core20 recall and outreach (p12)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN & Practice
    Option 2 · Asthma annual review recall audit (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Practice telephone access workflow review (p12)GPPS easy to contact the practice by phone · GPPS survey response rate10YHP, hospital to communityPractice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15